Journal Reviews

Tolerability and persistence in women prescribed mirabegron

1 November 2016 | | Functional Urology | Incontinence, Mirabegron, Overactive bladder, Persistence, Quality of life

Mirabegron is a beta-3 agonist used in the treatment of overactive bladder (OAB). Trials have shown reduced side-effects but equal efficacy when compared to anticholinergics. The authors wished to examine patients’ persistence with treatment, in a non-trial setting, over a...